Throughout her career, Amy has successfully managed Phase II-Phase IV trials, including Investigator-Initiated trials, in many different therapeutic areas. Her tenure on the sponsor side provides deep insights into trial design, data management, and risk- based monitoring, while her extensive site-level experience ensures seamless study start-up (including contract and budget negotiation), strong patient recruitment, and rigorous adherence to GCP. Amy is dedicated to advancing medical research and upholding the integrity of clinical data. She truly loves the field of pain management, partly due to close family members struggling with these issues. Amy is passionate about connecting patients with new and advanced treatment options beyond the standard of care, thus improving their quality of life.